5.46 - 5.56
4.95 - 8.28
1.7K / 2.4K (Avg.)
-276.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-8.10%
Negative revenue growth while VALMT.HE stands at 7.27%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-23.17%
Negative gross profit growth while VALMT.HE is at 11.66%. Joel Greenblatt would examine cost competitiveness or demand decline.
-51.00%
Negative EBIT growth while VALMT.HE is at 40.21%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-51.00%
Negative operating income growth while VALMT.HE is at 40.21%. Joel Greenblatt would press for urgent turnaround measures.
-70.84%
Negative net income growth while VALMT.HE stands at 39.44%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-70.53%
Negative EPS growth while VALMT.HE is at 42.11%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-70.53%
Negative diluted EPS growth while VALMT.HE is at 42.11%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-0.28%
Share reduction while VALMT.HE is at 0.02%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.28%
Reduced diluted shares while VALMT.HE is at 0.02%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
-87.66%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-152.85%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-17.85%
Negative 10Y revenue/share CAGR while VALMT.HE stands at 115.53%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-5.44%
Negative 5Y CAGR while VALMT.HE stands at 38.89%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
2.58%
3Y revenue/share CAGR under 50% of VALMT.HE's 27.03%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
449.55%
Positive long-term OCF/share growth while VALMT.HE is negative. John Neff would see a structural advantage in sustained cash generation.
-57.69%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-78.98%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
-6.73%
Negative 10Y net income/share CAGR while VALMT.HE is at 5275.70%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-53.37%
Negative 5Y net income/share CAGR while VALMT.HE is 133.73%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-62.69%
Negative 3Y CAGR while VALMT.HE is 85.37%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
94.40%
Below 50% of VALMT.HE's 207.23%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
58.86%
Below 50% of VALMT.HE's 133.48%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
46.18%
Below 50% of VALMT.HE's 104.21%. Michael Burry suspects a serious short-term disadvantage in building book value.
866.68%
Dividend/share CAGR of 866.68% while VALMT.HE is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
202.74%
5Y dividend/share CAGR above 1.5x VALMT.HE's 20.92%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
162.32%
Our short-term dividend growth is positive while VALMT.HE cut theirs. John Neff views it as a comparative advantage in shareholder returns.
-14.09%
Firm’s AR is declining while VALMT.HE shows 2.22%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-6.68%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-10.10%
Negative asset growth while VALMT.HE invests at 0.60%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-2.73%
We have a declining book value while VALMT.HE shows 3.41%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
0.42%
Debt shrinking faster vs. VALMT.HE's 24.21%. David Dodd sees a safer balance sheet if it doesn't impair future growth.
No Data
No Data available this quarter, please select a different quarter.
8.01%
We expand SG&A while VALMT.HE cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.